Insight Into Johnson & Johnson's Options Trends
Recent observations indicate a markedly bullish sentiment among significant investors regarding Johnson & Johnson. Wealthy investors, often referred to as "whales," have engaged in a variety of options trading, revealing their optimistic outlook for the company.
Analyzing Options History for JNJ
The options history for Johnson & Johnson (NYSE: JNJ) shows a total of 11 trades. Impressively, 72% of these trades reflect bullish expectations while no trades show a bearish stance.
Understanding the Trades
From the recorded trades, 4 were put options amounting to $411,540, while 7 were calls totaling $424,038. This modest activity signals a strong interest in the upward movement of JNJ stock.
Price Expectations and Forecasts
When reviewing the volume and open interest in these options contracts, analysts observe a price target range from $135.0 to $215.0 for Johnson & Johnson over the past quarter. This suggests that big players see value within this range.
Volume and Open Interest Analysis
Examining the volume and open interest is crucial for traders. It offers insights into the liquidity and overall interest in Johnson & Johnson’s options with respect to specific strike prices. A look back over the last 30 days reveals significant movements in volume and open interest for both call and put options.
Key Trades in Johnson & Johnson Options
The following significant options trades have been detected:
| Symbol | Trade Type | Sentiment | Expiration Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|
| JNJ | PUT | BULLISH | 01/16/26 | $210.00 | $222.0K | 4.1K | 569 |
| JNJ | CALL | BULLISH | 03/20/26 | $180.00 | $147.2K | 2.3K | 50 |
| JNJ | PUT | BULLISH | 01/15/27 | $210.00 | $103.8K | 119 | 60 |
| JNJ | CALL | NEUTRAL | 01/15/27 | $135.00 | $74.1K | 363 | 0 |
| JNJ | CALL | BULLISH | 01/02/26 | $210.00 | $60.5K | 469 | 589 |
About Johnson & Johnson
Johnson & Johnson stands out as the largest and most diversified healthcare company globally, operating through two primary segments: innovative medicine and medtech. Following the divestment of its consumer segment, Kenvue, which took place recently, the focus remains on critical therapeutic areas including immunology, oncology, and neurology, contributing to its revenue predominantly from the United States.
Current Position of Johnson & Johnson
- The stock is currently trading at a price of $205.64 with a minor decline of -0.07% on a volume of 1,499,052 shares.
- Technical indicators reveal that JNJ is stable, indicating neutral market conditions with no clear overbought or oversold signals.
- An earnings report is anticipated in the coming weeks, highlighting upcoming events for investors.
Expert Insights on Johnson & Johnson
In the last month, five analysts have voiced their opinions on Johnson & Johnson, projecting an average price target of $223.8. This variation in target prices among analysts indicates a diversity of opinions regarding JNJ's financial outlook.
Market Outlook Overview
Notably, analysts from RBC Capital have given an Outperform rating with a target of $230, while those at B of A Securities advise a Neutral stance with a target of $220. Morgan Stanley reflects caution with an Equal-Weight rating at $197, and Goldman Sachs maintains a Buy rating, projecting a $240 target. In line with these views, Citigroup has also issued a Buy rating with a target at $232.
Frequently Asked Questions
What is the current trading volume for JNJ?
The current trading volume for Johnson & Johnson is approximately 1,499,052 shares.
What are the recent price targets set by analysts for JNJ?
Analysts have recently set a range of price targets for JNJ, averaging around $223.8, with individual targets ranging from $197 to $240.
How does options trading work for Johnson & Johnson?
Options trading for JNJ involves speculating on the future movement of the stock, with various strategies employed to manage risk and maximize profits.
What sectors does Johnson & Johnson operate in?
Johnson & Johnson operates primarily in the healthcare sector, focusing on innovative medicines and medical technology.
What does the sentiment among big investors indicate?
The bullish sentiment from big investors suggests confidence in JNJ's future performance, based on their substantial options activity.
